Japanese researchers have uncovered a promising new use for henna, the ancient plant best known for its use in traditional body art. A new study by scientists at Osaka Metropolitan University suggests that a compound derived from henna, known as Lawsone, could help reverse liver fibrosis — a serious condition in which scar tissue forms in the liver, often leading to cirrhosis, liver failure, or even cancer.
A Scientific Breakthrough
The research team screened hundreds of chemical compounds and identified Lawsone as a key molecule capable of influencing hepatic stellate cells — the cells responsible for producing collagen and fibrous tissue after liver injury. When these cells remain chronically activated, they lead to fibrosis and scarring.
Laboratory and animal-model experiments revealed that Lawsone could lower the levels of several fibrosis markers, such as Yes-associated protein (YAP), alpha-smooth muscle actin (α-SMA), and Collagen type I alpha 1 (COL1A). At the same time, it increased the expression of cytoglobin (CYGB), a protective protein associated with reducing oxidative stress and keeping stellate cells in their less harmful, inactive state.
The compound was also found to improve the overall structure of liver tissue in mice, showing signs of actual repair rather than merely slowing down further damage.
Why the Study Matters
Liver fibrosis affects millions worldwide and remains a difficult condition to treat, as most available therapies only slow the disease’s progression without reversing existing damage. The discovery of a natural compound with regenerative potential could change that.
Because henna is already widely known for its cosmetic and cultural significance, researchers believe its medicinal potential deserves greater attention. However, they caution that this is still early-stage research. So far, the findings are based on cell and animal studies, and extensive human trials are necessary to determine its safety, dosage, and long-term effects.
The Larger Implication
If proven effective in humans, Lawsone could offer a safer, more accessible treatment for liver fibrosis and other diseases caused by excessive scar tissue, such as pulmonary or kidney fibrosis. The research team is already working on targeted delivery systems to transport the compound directly to the affected liver cells, which may enhance its effectiveness and minimize side effects.
Experts say that while the discovery is promising, liver health depends on multiple factors — including diet, alcohol consumption, body weight, and infections such as hepatitis. No single compound can substitute for preventive care and early medical intervention.
Looking Ahead
The Osaka Metropolitan University team plans to move forward with clinical research to confirm whether Lawsone can truly reverse fibrosis in human patients. If successful, the humble henna plant — long valued for beauty and tradition — may soon find a revolutionary place in modern medicine, offering hope to millions suffering from chronic liver disease.
